Ohio Zantac Lawyer
If you have taken the widely-used heartburn drug Zantac, it’s important to understand the possible dangers of this drug, which has come under the U.S. Food and Drug Administration’s (FDA) microscope in recent months. The FDA has pulled Zantac and its generic equivalents from shelves, citing concerns of unsafe levels of the impurity nitrosodimethylamine (NDMA), which is believed to be related to the active ingredient in Zantac, ranitidine. NDMA is a material known to cause cancer (probable carcinogen). NDMA has been found in both finished drug product samples and active product ingredients (APIs). All forms of ranitidine, including oral liquid/syrup, have been pulled off the market.
What is Zantac?
Zantac is a histamine-2 or H2 blocker, one of a group of medicines that reduced the amount of acid produced by the cells in the lining of the stomach. H2 blockers are common treatments for heartburn, along with acid reflux and other stomach, throat, and gastrointestinal issues. Zantac has been on the market since the early 1980’s, and generic forms of ranitidine have been available since 1997. These products are popular because they are fast-acting and effective. If you have taken Zantac and have been diagnosed with any of the following cancers, you may have a legal claim against the manufacturers of these products:
- Bladder Cancer
- Colorectal Cancer
- Esophageal Cancer
- Kidney Cancer
- Liver Cancer
- Lung Cancer
- Pancreatic Cancer
- Prostate Cancer
- Small Intestine Cancer
- Stomach Cancer
Concerns about ranitidine were first raised by the FDA in September 2019, when the FDA issued a warning to health care providers and patients that the impurity NDMA had been discovered in ranitidine. A voluntary recall followed shortly thereafter, with the FDA removing all Zantac and generic ranitidine products from the market in April 2020.
Free Zantac Cancer Lawsuit Evaluation
Many lawsuits have already been filed against GlaxoSmithKline, the original maker of branded Zantac, and it is important to get involved in these lawsuits early, if possible. GBM Law is actively reviewing and investigating Zantac lawsuits and legal actions. If you would like a free consultation, we will review your case and evaluate legal action against the manufacturers of the drug, along with distributors and sellers. Your case will be handled on a contingency fee basis, which means there are zero out-of-pocket or up-front fees. We are only paid, if and when, we recover money for you.
What is ranitidine, commonly sold under the brand name Zantac?
These medications were sold both by prescription and over the counter and were used to prevent and treat heartburn, or acid reflux. Heartburn is one of the most common medical conditions in the United States, with reports of 60 million Americans experiencing heartburn at least once a month. Generally, ranitidine medications, including Zantac, were commonly prescribed or purchased over the counter to treat those conditions for many years.
How is ranitidine, sold under the brand name Zantac, causing cancer?
These medications are believed to contact a cancer-causing chemical called NDMA. NDMA is a semi-volatile organic chemical known to be toxic and cancer-causing to the liver as well as other organs. While NDMA is also an environmental contaminant, ranitidine (Zantac) has been connected to high levels of this cancer-causing impurity.
Was Zantac recalled?
Yes, in October 2019, the Food and Drug Administration (FDA) issued a warning that Zantac and other generic formulations of ranitidine are contaminated with NDMA, a dangerous chemical that potentially causes cancer. Subsequently, the FDA recalled Zantac and all ranitidine containing medications.
I used Zantac. Do I have a case?
If you used Zantac or generic ranitidine for more than 1 year and subsequently were diagnosed with bladder, breast, colorectal/intestinal, esophageal, stomach/gastric, kidney, liver, lung, pancreatic, and prostate cancers, you may have a case. Contact GBM Law to review the details of your situation to find out more.